David A. Jenkins - 05 Dec 2025 Form 4 Insider Report for Catheter Precision, Inc. (VTAK)

Reporting relationship: Chairman of the Board and CEO
Issuer ticker: VTAK
Reported as of: 05 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Dec 2025, 16:45:07 UTC
Prior SEC filing: 14 Aug 2025
Next SEC filing: 20 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ David A Jenkins

Key filing fact

David A. Jenkins filed Form 4 for Catheter Precision, Inc. (VTAK) on 08 Dec 2025.

Key facts

This page summarizes David A. Jenkins's Form 4 filing for Catheter Precision, Inc. (VTAK).
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 08 Dec 2025, 16:45.

Change

Previous filing in this sequence was filed on 14 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001279803 Primary reporting owner

JENKINS DAVID A

Relationship: Chairman of the Board and CEO
Address: 1670 HIGHWAY 160 WEST, SUITE 205, FORT MILL
Signature: /s/ David A Jenkins
Signature date: 08 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VTAK transaction

Common Stock

Conversion of derivative security

Transaction value: $0
Shares: +12,064
Change %: +695%
Price: $0.000000
Shares after: 13,799
Date: 05 Dec 2025
Ownership: Direct

VTAK transaction

Common Stock

Conversion of derivative security

Transaction value: $0
Shares: +30,844
Change %: +826%
Price: $0.000000
Shares after: 34,579
Date: 05 Dec 2025
Ownership: See Footnote
Footnotes: F1

VTAK transaction

Common Stock

Conversion of derivative security

Transaction value: $0
Shares: +98
Change %: +891%
Price: $0.000000
Shares after: 109
Date: 05 Dec 2025
Ownership: See Footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTAK transaction Derivative

Series X Convertible Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -2,292
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F3

VTAK transaction Derivative

Series X Convertible Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -5,861
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Dec 2025
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F1, F3

VTAK transaction Derivative

Series X Convertible Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -19
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Dec 2025
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares held by a partnership of which the reporting person is the managing member of the managing partner

Footnote F2

Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee

Footnote F3

Series X Convertible Preferred Stock has no expiration date

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .